v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells

Oncogene. 2000 Mar 23;19(13):1710-8. doi: 10.1038/sj.onc.1203497.

Abstract

We investigated the effect of cell transformation by v-src on the expression and tyrosine phosphorylation of SHPS-1, a putative docking protein for SHP-1 and SHP-2. We found that transformation by v-src virtually inhibited the SHPS-1 expression at mRNA level. While nontransforming Src kinases including c-Src, nonmyristoylated forms of v-Src had no inhibitory effect on SHPS-1 expression, transforming Src kinases including wild-type v-Src and chimeric mutant of c-Src bearing v-Src SH3 substantially suppressed the SHPS-1 expression. In cells expressing temperature sensitive mutant of v-Src, suppression of the SHPS-1 expression was temperature-dependent. In contrast, tyrosine phosphorylation of SHPS-1 was rather activated in cells expressing c-Src or nonmyristoylated forms of v-Src. SHPS-1 expression in SR3Y1 was restored by treatment with herbimycin A, a potent inhibitor of tyrosine kinase, or by the expression of dominant negative form of Ras. Contrary, active form of Mekl markedly suppressed SHPS-1 expression. Finally, overexpression of SHPS-1 in SR3Y1 led to the drastic reduction of anchorage independent growth of the cells. Taken together, our results suggest that the suppression of SHPS-1 expression is a pivotal event for cell transformation by v-src, and the Ras-MAP kinase cascade plays a critical role in the suppression.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Acylation
  • Animals
  • Antigens, Differentiation*
  • Avian Sarcoma Viruses / genetics
  • Avian Sarcoma Viruses / physiology*
  • Benzoquinones
  • Cell Adhesion
  • Cell Division
  • Cell Line, Transformed
  • Cell Transformation, Viral / genetics
  • Cell Transformation, Viral / physiology*
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts
  • Gene Expression Regulation, Viral*
  • Genes, src*
  • Half-Life
  • Lactams, Macrocyclic
  • MAP Kinase Kinase Kinase 1*
  • MAP Kinase Signaling System*
  • Membrane Glycoproteins / biosynthesis*
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / immunology
  • Mice
  • Myristic Acid / metabolism
  • Neural Cell Adhesion Molecule L1*
  • Neural Cell Adhesion Molecules / biosynthesis*
  • Neural Cell Adhesion Molecules / genetics
  • Neural Cell Adhesion Molecules / immunology
  • Oncogene Protein pp60(v-src) / chemistry
  • Oncogene Protein pp60(v-src) / genetics
  • Oncogene Protein pp60(v-src) / physiology*
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Protein Processing, Post-Translational
  • Protein Serine-Threonine Kinases / metabolism
  • Quinones / pharmacology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Rats
  • Receptors, Immunologic*
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Fusion Proteins / immunology
  • Recombinant Fusion Proteins / physiology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rifabutin / analogs & derivatives
  • Transfection
  • ras Proteins / physiology*
  • src-Family Kinases / physiology

Substances

  • Antigens, Differentiation
  • Benzoquinones
  • Enzyme Inhibitors
  • Lactams, Macrocyclic
  • Membrane Glycoproteins
  • Neural Cell Adhesion Molecule L1
  • Neural Cell Adhesion Molecules
  • Sirpa protein, mouse
  • Quinones
  • RNA, Messenger
  • Receptors, Immunologic
  • Recombinant Fusion Proteins
  • Sirpa protein, rat
  • Myristic Acid
  • Rifabutin
  • herbimycin
  • Oncogene Protein pp60(v-src)
  • src-Family Kinases
  • Protein Serine-Threonine Kinases
  • Protein Kinase C
  • MAP Kinase Kinase Kinase 1
  • Map3k1 protein, mouse
  • ras Proteins